Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-01

Clinical Trial Update: Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of adding topiramate to current treatment in refractory obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: McMaster University | Conditions: Obsessive Compulsive Disorder | Phase 4 | Status: COMPLETED